EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Is it tuberculosis or chronic pulmonary aspergillosis? Diagnostic challenges, consequences of misdiagnosis, and potential solutions in resource-limited settings

Bahareh Bagheri iD, David W Denning, Alfred Botha iD, Pamela Ncube, Samantha L Sampson

Clinical Microbiology Reviews · 03.11.2026

DOI: 10.1128/cmr.00195-24 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Clinical Microbiology Reviews, online erschienen am 03.11.2026. Verfasst von Bahareh Bagheri und 4 weiteren Autor:innen. Beteiligte Einrichtung: DSI/NRF Centre of Excellence for Biomedical Tuberculosis Research, South African Medical Research Council Centre for Tuberculosis Research, Division …. Die Arbeit nennt 230 Literaturangaben. Gefördert von: National Research Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Chronic pulmonary aspergillosis (CPA) is most often caused by Aspergillus fumigatus and carries significant mortality and morbidity. While the diagnosis of CPA is often delayed, the emergence of CPA among patients with a concurrent or previous history of mycobacterial disease presents a challenge for CPA diagnosis. When patients previously treated for mycobacterial diseases present with new symptoms, it is often unclear whether these symptoms are due to a recurrence of pulmonary tuberculosis (PTB), non-tuberculous mycobacteria (NTM) infection, CPA, co-infection, or another of several other differential diagnoses. Consequently, PTB patients can be misdiagnosed as having smear/GeneXpert-negative PTB. We address these challenges, given the different associated mortality and morbidity of NTM, PTB, and CPA. We proposed a new algorithm to guide clinicians in ruling CPA in or out in both newly diagnosed smear/GeneXpert-negative and NTM patients and those with a previous history of mycobacterial disease. We also recommend follow-up screening of those with a high risk of developing CPA following their PTB/NTM treatment. Implementing screening strategies, such as performing end-of-treatment TB chest X-rays and Aspergillus -specific IgG tests during and at the end of mycobacterial therapy, could facilitate the early diagnosis and treatment of CPA and alleviate associated mortality and morbidity.

Schlagwörter

Stichwörter der Autor:innen

CPA misdiagnosisCPA screeningchronic pulmonary aspergillosisnon-tuberculous mycobacteriapulmonary tuberculosissmear-negative

Autor:innen und Institutionen

  • DSI/NRF Centre of Excellence for Biomedical Tuberculosis Research, South African Medical Research Council Centre for Tuberculosis Research, Division of Molecular Biology and Human Genetics, Department of Biomedical Scie…
  • Faculty of Biology, Medicine, and Health, University of Manchester, Manchester Academic Health Science Centre, Manchester, United Kingdom.
  • Department of Microbiology, Stellenbosch University, Stellenbosch, South Africa.

ORCID-Profile: Bahareh Bagheri, Alfred Botha

Förderung

  • National Research Foundation

Zitieren

APA

Bagheri, B., Denning, D. W., Botha, A., Ncube, P., & Sampson, S. L. (2026). Is it tuberculosis or chronic pulmonary aspergillosis? Diagnostic challenges, consequences of misdiagnosis, and potential solutions in resource-limited settings. Clinical Microbiology Reviews. https://doi.org/10.1128/cmr.00195-24

Vancouver

Bagheri B, Denning DW, Botha A, Ncube P, Sampson SL. Is it tuberculosis or chronic pulmonary aspergillosis? Diagnostic challenges, consequences of misdiagnosis, and potential solutions in resource-limited settings. Clinical Microbiology Reviews. 2026. doi:10.1128/cmr.00195-24

BibTeX
@article{Bagheri2026,
  author = {Bagheri, Bahareh and Denning, David W and Botha, Alfred and Ncube, Pamela and Sampson, Samantha L},
  title = {Is it tuberculosis or chronic pulmonary aspergillosis? Diagnostic challenges, consequences of misdiagnosis, and potential solutions in resource-limited settings},
  journal = {Clinical Microbiology Reviews},
  year = {2026},
  doi = {10.1128/cmr.00195-24}
}
Kostenlos starten →